Anuh Pharma Limited (IN:ANUHPHR)
:ANUHPHR
Want to see IN:ANUHPHR full AI Analyst Report?
Total Valuation
Anuh Pharma Limited has a market cap or net worth of ₹7.78B. The enterprise value is ₹7.91B.
Market Cap₹7.78B
Enterprise Value₹7.91B
Share Statistics
Anuh Pharma Limited has 100,224,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding100,224,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Anuh Pharma Limited’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 10.75%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)10.75%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee26.16M
Profits Per Employee1.39M
Employee Count295
Asset Turnover1.38
Inventory Turnover4.31
Valuation Ratios
The current PE Ratio of Anuh Pharma Limited is 19.2. Anuh Pharma Limited’s PEG ratio is -1.25.
PE Ratio19.2
PS Ratio0.87
PB Ratio1.91
Price to Fair Value1.91
Price to FCF-61.98
Price to Operating Cash Flow64.63
PEG Ratio-1.25
Income Statement
In the last 12 months, Anuh Pharma Limited had revenue of 7.72B and earned 410.46M in profits. Earnings per share was 4.10.
Revenue7.72B
Gross Profit1.34B
Operating Income503.38M
Pretax Income542.21M
Net Income410.46M
EBITDA660.76M
Earnings Per Share (EPS)4.10
Cash Flow
In the last 12 months, operating cash flow was 121.88M and capital expenditures -180.40M, giving a free cash flow of -58.52M billion.
Operating Cash Flow121.88M
Free Cash Flow-58.52M
Free Cash Flow per Share-0.58
Dividends & Yields
Anuh Pharma Limited pays an annual dividend of ₹1.5, resulting in a dividend yield of 1.92%
Dividend Per Share₹1.5
Dividend Yield1.92%
Payout Ratio38.83%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.69
52-Week Price Change-22.45%
50-Day Moving Average79.32
200-Day Moving Average79.85
Relative Strength Index (RSI)48.71
Average Volume (3m)6.00K
Important Dates
Anuh Pharma Limited upcoming earnings date is Aug 7, 2026, TBA (Confirmed).
Last Earnings DateMay 20, 2026
Next Earnings DateAug 7, 2026
Ex-Dividend Date―
Financial Position
Anuh Pharma Limited as a current ratio of 2.22, with Debt / Equity ratio of 0.02%
Current Ratio2.22
Quick Ratio1.50
Debt to Market Cap0.00
Net Debt to EBITDA-0.12
Interest Coverage Ratio106.58
Taxes
In the past 12 months, Anuh Pharma Limited has paid 131.75M in taxes.
Income Tax131.75M
Effective Tax Rate0.24
Enterprise Valuation
Anuh Pharma Limited EV to EBITDA ratio is 10.04, with an EV/FCF ratio of -61.22.
EV to Sales0.86
EV to EBITDA10.04
EV to Free Cash Flow-61.22
EV to Operating Cash Flow-223.24
Balance Sheet
Anuh Pharma Limited has ₹135.33M in cash and marketable securities with ₹2.27M in debt, giving a net cash position of ₹133.05M billion.
Cash & Marketable Securities₹135.33M
Total Debt₹2.27M
Net Cash₹133.05M
Net Cash Per Share₹1.33
Tangible Book Value Per Share₹35.13
Margins
Gross margin is 19.79%, with operating margin of 6.52%, and net profit margin of 5.32%.
Gross Margin19.79%
Operating Margin6.52%
Pretax Margin7.03%
Net Profit Margin5.32%
EBITDA Margin8.56%
EBIT Margin7.09%
Analyst Forecast
The average price target for Anuh Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast16.65%
EPS Growth Forecast-13.22%